Skip to main content
. 2016 Nov 3;7(11):e2456. doi: 10.1038/cddis.2016.287

Figure 8.

Figure 8

Model of the serglycin–CD44 signaling pathway in NPC. Serglycin binds to CD44 and activates MAPK signaling to subsequently promote β-catenin translocation from the membrane compartment to the nucleus. Note the positive feedback loop in which CD44 is the upstream activator and the downstream transcriptional target of the MAPK/β-catenin pathway